Edick Paul R

Average Profitability
2.62%
Insider Buys Quantity
11
Insider Buys Sum
$1.96M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Edick Paul R

The largest purchase of all time was on 2019-03-11 and amounted to 60000 shares of Xeris Biopharma Holdings, Inc. for $547,170.

Biography of Edick Paul R

No biography is available at this moment.

2023-08-09PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
10,000
0.0073%
$2.38$23,794-10.64%
2022-12-13PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
20,000
0.0152%
$1.45$29,000+34.75%
2022-05-12PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
100,000
0.0681%
$1.40$140,380+0.66%
2021-11-15PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
20,000
0.0151%
$2.28$45,664-17.14%
2021-11-11PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
200,000
0.1644%
$2.08$415,7600%
2020-12-09PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
20,000
0.0376%
$4.06$81,102-9.43%
2020-05-08PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
66,000
0.1614%
$3.00$198,000+45.82%
2020-02-14PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
40,000
0.1266%
$4.15$166,000+12.75%
2019-11-25PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
35,870
0.1314%
$8.55$306,567-46.76%
2019-03-11PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
60,000
0.2508%
$9.12$547,170+2.92%
2018-08-23PurchaseIterum Therapeutics plc
ITRM
director
1,000
0.0074%
$10.44$10,437-34.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.